Geza Acs, Paul J. Zhang, Timothy R. Rebbeck, Peter Acs and Ajay Verma Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma Cancer 95
Article first published online: 19 AUG 2002 | DOI: 10.1002/cncr.10787
Benign mammary epithelial cells and cells of in situ and invasive breast carcinomas express both erythropoietin (Epo) and Epo receptor (EpoR). Increased EpoR immunostaining in breast carcinomas is correlated with clinicohistopathologic features suggestive of an adverse prognosis. Increased autocrine Epo signaling may represent a novel mechanism by which hypoxia promotes breast carcinoma and induces a malignant phenotype.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field